Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vivo Cannabis Inc
(OP:
VVCIF
)
N/A
UNCHANGED
Last Price
Updated: 3:09 PM EDT, Apr 4, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vivo Cannabis Inc
< Previous
1
2
Next >
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
April 13, 2023
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabis Inc.'s (OTCQB: VVCIF) operations follow
Via
Benzinga
The Canadian Cannabis Report - Monday, April 10
April 10, 2023
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks.
Via
Talk Markets
The Canadian Cannabis Report - Monday, April 3
April 03, 2023
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 18 stocks.
Via
Talk Markets
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
March 31, 2023
MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021.
Via
Benzinga
VIVO Cannabis Announces Fourth Quarter 2022 Results
March 28, 2023
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter.Net revenue for 2022 was $25.4 million,...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Obtains Final Court Order Approving Its Plan of Arrangement with MediPharm
March 24, 2023
Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO") is pleased to announce...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Signs Agreement To Amend Outstanding Debentures
September 19, 2022
VIVO Cannabis Inc.
Via
Benzinga
MediPharm Labs Shareholders Approve Merger With VIVO Cannabis
March 22, 2023
MediPharm Labs Corp.
Via
Benzinga
VIVO Cannabis Announces Approval of Proposed Arrangement at Special Meeting of Shareholders
March 21, 2023
Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO") is pleased to announce...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs To Acquire VIVO Cannabis
December 22, 2022
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE: MLZ) and VIVO Cannabis Inc.
Via
Benzinga
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
December 22, 2022
Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, Dec. 19
December 19, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks.
Via
Talk Markets
The Cannabis Canadian Report - Monday, Dec. 5
December 05, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks.
Via
Talk Markets
The Canadian Cannabis Report - Monday, Nov.28
November 28, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks.
Via
Talk Markets
Vivo Cannabis Q3 Revenue Improves 19% YoY Driven By Increased International Sales
November 15, 2022
Vivo Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) released Monday its third-quarter 2022 financial and operating results with revenue of CA$6.2 million ($4.67 million), in line with the same period of last...
Via
Benzinga
VIVO Cannabis Announces Third Quarter 2022 Results
November 14, 2022
Net revenue for Q3 2022 was $6.2 million, a 19% increase from prior quarterInternational sales reach $2.5 million Beacon Medical...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Announces Third Supplemental Debenture Indenture
October 03, 2022
Toronto, Ontario--(Newsfile Corp. - October 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") is...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Announces Agreement to Amend Outstanding Debentures
September 19, 2022
Toronto, Ontario--(Newsfile Corp. - September 19, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") has...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Announces Second Quarter 2022 Results
August 15, 2022
Net revenue for Q2 2022 was $5.2 millionCompany announced that Canna Farms received a Research Licence from Health Canada in...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
VIVO Cannabis Subsidiary Canna Farms Granted Research License By Health Canada
July 22, 2022
Canna Farms a wholly-owned subsidiary of VIVO Cannabis Inc. (OTCQX: VVCIF) (TSX:VIVO) has received a research license from Health Canada allowing it to possess cannabis for the purpose of research.
Via
Benzinga
VIVO Cannabis Announces Canna Farms Granted Research Licence by Health Canada
July 22, 2022
Toronto, Ontario--(Newsfile Corp. - July 22, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, June 20
June 20, 2022
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
VIVO Cannabis Announces First Quarter 2022 Results
May 16, 2022
Net revenue for Q1 2022 was $6.9 millionVIVO continues to pursue its international expansion strategy which now represents >50% of...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, May 16
May 16, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
VIVO Cannabis Announces Fourth Quarter 2021 Results
March 31, 2022
Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million.In February 2021, closed a $7.2...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, March 28
March 28, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
The Canadian Cannabis Report - Monday, Feb. 28
February 28, 2022
The past, present, and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora
February 17, 2022
According to Coherent Market Insights, the global cannabis extract market is estimated to be valu...
Via
Benzinga
Cicatrix Labs Announces Launch of Assuage Brand Suppositories to the Canadian Market
February 14, 2022
Kelowna, British Columbia--(Newsfile Corp. - February 14, 2022) - Cicatrix Labs Ltd, a holder of a cannabis processing license under...
Via
Newsfile
Topics
Cannabis
Law Enforcement
Exposures
Cannabis
Legal
VIVO Cannabis(TM) Adds Assuage Suppositories to Online Medical Marketplace
February 11, 2022
Toronto, Ontario--(Newsfile Corp. - February 11, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.